BioSpace News Archive

Business

BioAxone BioSciences Appoints Ronald S. Goldstein as CFO

- Brings Experience Across Full Spectrum of Corporate Finance –

April 10, 2018
·
2 min read
Business

Amgen Announces Rhode Island Will Be Location Of First US Next-Generation Biomanufacturing Plant

Revolutionary, Innovative Plant Offers Greater Flexibility, Speed and Efficiency

April 10, 2018
·
9 min read
FDA

FDA clears first contact lens with light-adaptive technology

The U.S. Food and Drug Administration today cleared the first contact lens to incorporate an additive that automatically darkens the lens when exposed to bright light

April 10, 2018
·
3 min read
Lone Star Bio

Vizient, Inc. Applauds DEA for Taking Steps to Help Alleviate Opioid Shortages in Hospitals

Vizient, Inc. applauds the Drug Enforcement Administration (DEA) for working with health care industry stakeholders to take steps to alleviate certain drug shortages facing the nation’s acute care providers.

April 10, 2018
·
2 min read
JPT Peptide Technologies Launches The Human Proteome Peptide Catalog

JPT Peptide Technologies (JPT) announces the launch of The Human Proteome Peptide Catalog, the first and most comprehensive online resource for validated reference peptides in mass-spectrometry based proteomics.

April 10, 2018
·
2 min read
Pfizer’s Xeljanz Barrels into Psoriatic Arthritis, Leaving Lilly’s Recently Launched Taltz in its Wake, According to a Recently Published Study from Spherix Global Insights

Janssen’s Simponi Aria and BMS’ Orencia seem to be settling into their respective niches, but neither brand is anticipated to bring much disruption to the PsA market

April 10, 2018
·
4 min read
Drug Development

ARKAY Therapeutics Submits Investigational New Drug (IND) Application for RK-01, a First-in Class ‘Beta-cell-centric’ Drug Combination Product for Type 2 Diabetes

First Human Proof-of-Concept (PoC) Trial to Test the Superiority of RK-01 over Metformin in Type 2 Diabetes Patients with Inadequate Glycemic Control.

April 10, 2018
·
6 min read